*Free registration required
Annual Update
HIV and Hepatitis C Annual Update 2012
Expert faculty members review scientific and clinical advances of the past year.
Now Available!
CME/CE/ACPE-Certified Modules:
 |
Using
Boceprevir and Telaprevir in Clinical PracticeMichael W. Fried, MD,
reviews key factors that patients and treatment providers must consider before
beginning boceprevir- or telaprevir-based triple therapy as well as important
on-treatment management strategies.
|
 |
New
HCV AgentsDavid R. Nelson, MD, reviews the latest data on
emerging agents under investigation for the treatment of chronic HCV
infection.
|
 |
Management
of Tuberculosis in HIV-Infected PatientsRichard E. Chaisson,
MD, reviews the latest data on key issues related to the prevention, diagnosis,
and treatment of tuberculosis in patients with HIV
infection.
|
 |
Optimal
Use of Direct-Acting Antiviral Agents in the Treatment of HIV/HCV-Coinfected
PatientsJürgen K. Rockstroh, MD, reviews current guidelines and
recent clinical data and provides expert perspective regarding the concomitant
use of HIV and HCV therapies in coinfected
patients.
|
Coming Soon!
CME/CE/ACPE-Certified Modules:
 |
2012 Update on Antiretroviral Therapy |
 |
Long-term Complications of HIV and Antiretroviral Therapy |
Downloadable PowerPoint Slideset:
| HIV and Hepatitis C Annual Update 2012 |
No comments:
Post a Comment